Amanote Research
Register
Sign In
MA08.01 Phase 3 Trial of Whole Brain Radiotherapy With Concurrent Erlotinib Versus WBRT Alone for NSCLC With Brain Metastases (ENTER)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.376
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Z. Yang
Y. Zhang
R. Li
A. Yisikandaer
B. Ren
J. Sun
J. Li
L. Chen
R. Zhao
J. Zhang
Publisher
Elsevier BV
Related search
P2.01-127 Efficacy of Endostar Combined With Whole Brain Radiotherapy in Patients With NSCLC Brain Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Whole Brain Radiotherapy (WBRT) After Local Treatment of Brain Metastases in Melanoma Patients: Statistical Analysis Plan
Trials
Medicine
Pharmacology
WBRT Plus SIB With Image Guided Intensity-Modulated Radiotherapy for Multiple Brain Metastases
Cancer therapy & Oncology International Journal
Phase II Clinical Trial of Whole-Brain Irradiation Plus Three-Dimensional Conformal Boost With Concurrent Topotecan for Brain Metastases From Lung Cancer
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Successful Treatment of Carcinomatous Meningitis With Erlotinib and Whole Brain Radiotherapy
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
MA08.03 EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR Mutated NSCLC Patients With Brain Metastases: A Meta-Analysis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Meta-Analysis
PLoS ONE
Multidisciplinary
Whole Brain Radiation Therapy Alone Versus Radiosurgery for Patients With 1–10 Brain Metastases From Small Cell Lung Cancer (ENCEPHALON Trial): Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
P1.01-100 Concurrent Brain Radiotherapy and EGFR-TKI Have Better Survival Benefits in Patients With Brain Metastases From EGFR-Mutant NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary